Objective: The aim of this study was to investigate the possible association between the acute to chronic (A/C) glycemic ratio and the presence of erectile dysfunction (ED) in diabetic men. Material and Methods: A total of 104 diabetic men, 45 of whom had ED while 59 did not, were retrospectively enrolled in this study. Clinical examination and laboratory analyses including A/C glycemic ratio, serum fasting glucose, hemoglobin A1c, lipid profile, and total testosterone were analyzed. Results: The total testosterone levels were lower in the diabetic ED patients compared to the non-ED diabetic participants (4.49 ng/dL vs 4.80 ng/dL, respectively). However, the difference was not statistically significant (p=0.093). Mean high-density lipoprotein cholesterol levels were significantly lower in the diabetic ED patients than in the controls (40±9 mg/dL vs 44±10 mg/dL; respectively; p=0.030). Although the median A/C glycemic ratios were higher in the diabetic ED patients (1.28±0.23 vs. 1.18±0.32), no statistical significant differences were noted between the two groups (p=0.054) Conclusion: The strong relationship between diabetes mellitus (DM) and ED demands caution since DM is a common disease in the population. We believe that developing biomarkers for the early diagnosis of ED will help provide treatment and improve the life quality of patients. Although we could not find a statistical relationship between the A/C glycemic ratio and ED in our study results, we think that further welldesigned prospective studies are needed in this area.
Keywords: Acute to chronic glycemic ratio; diabetes mellitus; erectile dysfunction
Amaç: Bu çalışmanın amacı, diyabetik erkeklerde akut-kronik (A/K) glisemik oran ile erektil disfonksiyon (ED) arasındaki muhtemel ilişkiyi araştırmaktır. Gereç ve Yöntemler: Kırk beşinde ED olan 59'unda olmayan toplam 104 diyabetik erkek retrospektif olarak çalışmaya dâhil edildi. Klinik muayeneleri ve A/K glisemik oranı, serum açlık glukoz, hemoglobin A1c, lipid profili ve total testosteron düzeyleri dâhil olmak üzere laboratuvar bulguları incelendi. Bulgular: Total testosteron düzeyleri diyabetik ED hastalarında ED olmayan diyabetik katılımcılara göre daha düşüktü (4,49 ng/dL vs 4,80 ng/dL, sırasıyla) ancak bu fark istatistiksel olarak anlamlı değildi (p=0,093). Ortalama yüksek-yoğunluklu lipoprotein kolesterol düzeyleri diyabetik ED hastalarında kontrollere göre anlamlı olarak daha düşüktü (40±9 mg/dL vs 44±10 mg/dL; sırasıyla; p=0,030). Ortanca A/K glisemik oranları ED hastalarında daha yüksek olsa da (1,28±0,23 vs. 1,18±0,32), 2 grup arasında istatistiksel anlamlı farklılık izlenmedi (p=0,054). Sonuç: Diabetes mellitus (DM) ve ED arasındaki güçlü bir bağ bulunması ve DM'nin toplumda sık bir hastalık olması sebebiyle bu ilişkiye dikkat edilmelidir. ED'nin erken tanısı için biyobelirteçler geliştirmenin tedavide ve hastaların yaşam kalitesini artırmada yardımcı olacağına inanıyoruz. Çalışma sonuçlarımızda, A/K glisemik oranı ve ED arasında istatistiksel anlamlı ilişki bulamasak da bu konuda gelecekte iyi tasarlanmış prospektif çalışmalara ihtiyaç duyulduğu düşüncesindeyiz.
Anahtar Kelimeler: Akut-kronik glisemik oran; diyabetes mellitus; erektil disfonksiyon
- Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED Jr, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010;7(4 Pt 2):1598-607. [Crossref] [PubMed]
- NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA. 1993;270(1):83-90. [Crossref] [PubMed]
- Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res. 2003;15(1):63-71. [Crossref] [PubMed]
- Shiri R, Hakama M, Häkkinen J, Tammela TL, Auvinen A, Koskimäki J. Relationship between smoking and erectile dysfunction. Int J Impot Res. 2005;17(2):164-9. [Crossref] [PubMed]
- Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151-7. [Crossref] [PubMed]
- Sáenz de Tejada I, Anglin G, Knight JR, Emmick JT. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care. 2002;25(12):2159-64. [Crossref] [PubMed]
- Oyelade BO, Jemilohun AC, Aderibigbe SA. Prevalence of erectile dysfunction and possible risk factors among men of South-Western Nigeria: a population based study. Pan Afr Med J. 2016;24:124. [PubMed] [PMC]
- Al-Hunayan A, Al-Mutar M, Kehinde EO, Thalib L, Al-Ghorory M. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int. 2007;99(1):130-4. [Crossref] [PubMed]
- Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-8. Erratum in: Diabetes Care. 2009;32(1):207. [Crossref] [PubMed] [PMC]
- Marenzi G, Cosentino N, Milazzo V, De Metrio M, Cecere M, Mosca S, et al. Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: a prospective study. Diabetes Care. 2018;41(4):847-53. [Crossref] [PubMed]
- Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, et al; Turkish Erectile Dysfunction Prevalence Study Group. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol. 2002;41(3):298-304. [Crossref] [PubMed]
- Burke JP, Jacobson DJ, McGree ME, Nehra A, Roberts RO, Girman CJ, et al. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. J Urol. 2007;177(4):1438-42. [Crossref] [PubMed]
- Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta: Centers for Disease Control and Prevention; 2014. [Link]
- Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014;2014(2):CD009122. [Crossref] [PubMed] [PMC]
- Morano S. Pathophysiology of diabetic sexual dysfunction. J Endocrinol Invest. 2003;26(3 Suppl):65-9. [PubMed]
- Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423-36. [Crossref] [PubMed]
- Patel DP, Craig JR Jr, Myers JB, Brant WO, Hotaling JM. Serum biomarkers of erectile dysfunction in diabetes mellitus: a systematic review of current literature. Sex Med Rev. 2017;5(3):339-48. [Crossref] [PubMed]
- Binmoammar TA, Hassounah S, Alsaad S, Rawaf S, Majeed A. The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review. JRSM Open. 2016;7(3):2054270415622602. [Crossref] [PubMed] [PMC]
- Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O'Dea H, Stranks SN, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490-7. [Crossref] [PubMed]
- Su YW, Hsu CY, Guo YW, Chen HS. Usefulness of the plasma glucose concentration-to-HbA1c ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. Diabetes Metab. 2017;43(1):40-7. [Crossref] [PubMed]
- Lee TF, Burt MG, Heilbronn LK, Mangoni AA, Wong VW, McLean M, et al. Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data. Cardiovasc Diabetol. 2017;16(1):157. [Crossref] [PubMed] [PMC]
- Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000;12(6):305-11. [Crossref] [PubMed]
- Shiverick KT, Salafia C. Cigarette smoking and pregnancy I: ovarian, uterine and placental effects. Placenta. 1999;20(4):265-72. [Crossref] [PubMed]
- Giugliano D, Giugliano F, Esposito K. Sexual dysfunction and the Mediterranean diet. Public Health Nutr. 2006;9(8A):1118-20. [Crossref] [PubMed]
- McMahon CG, Touma K. Predictive value of patient history and correlation of nocturnal penile tumescence, colour duplex Doppler ultrasonography and dynamic cavernosometry and cavernosography in the evaluation of erectile dysfunction. Int J Impot Res. 1999;11(1):47-51. [Crossref] [PubMed]
- Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al; European Association of Urology. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804-14. [Crossref] [PubMed]
- Martínez-Jabaloyas JM, Queipo-Zaragozá A, Pastor-Hernández F, Gil-Salom M, Chuan-Nuez P. Testosterone levels in men with erectile dysfunction. BJU Int. 2006;97(6):1278-83. [Crossref] [PubMed]
- Rastrelli G, Corona G, Maggi M. Testosterone and sexual function in men. Maturitas. 2018;112:46-52. [Crossref] [PubMed]
- Rhoden EL, Telöken C, Sogari PR, Souto CA. The relationship of serum testosterone to erectile function in normal aging men. J Urol. 2002;167(4):1745-8. [Crossref] [PubMed]
- Chew KK, Bremner A, Stuckey B, Earle C, Jamrozik K. Is the relationship between cigarette smoking and male erectile dysfunction independent of cardiovascular disease? Findings from a population-based cross-sectional study. J Sex Med. 2009;6(1):222-23. [Crossref] [PubMed]
- Authors/Task Force Members:, Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and european atherosclerosis society (EAS) developed with the special contribution of the european assocciation for cardiovascular prevention & rehabilitation (EACPR). Atherosclerosis. 2016;253:281-344. [PubMed]
- Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886-99. [Crossref] [PubMed] [PMC]
- Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384(9943):618-25. [Crossref] [PubMed]
- Yao F, Huang Y, Zhang Y, Dong Y, Ma H, Deng C, et al. Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease. Int J Androl. 2012;35(5):653-9. [Crossref] [PubMed]
- Li M, Ma Z, Zhang XL, Guo LQ, Yuan MZ. Significance of blood lipid parameters as effective markers for arteriogenic erectile dysfunction. Andrology. 2020;8(5):1086-94. [Crossref] [PubMed]
.: İşlem Listesi